BRISTOL-MYERS DISCONTINUING OTC CAPSULE BUSINESS WITH PLANS TO INTRODUCE NEW CAPLET DOSAGES BY JULY; EXCEDRIN TAMPERING FORCES MARKET WITHDRAWAL

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".